GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DaVita Inc (BSP:DVAI34) » Definitions » Days Sales Outstanding
中文

DaVita (BSP:DVAI34) Days Sales Outstanding : 58.42 (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is DaVita Days Sales Outstanding?

DaVita's average Accounts Receivable for the three months ended in Dec. 2023 was R$9,868 Mil. DaVita's Revenue for the three months ended in Dec. 2023 was R$15,414 Mil. Hence, DaVita's Days Sales Outstanding for the three months ended in Dec. 2023 was 58.42.

The historical rank and industry rank for DaVita's Days Sales Outstanding or its related term are showing as below:

BSP:DVAI34' s Days Sales Outstanding Range Over the Past 10 Years
Min: 42.95   Med: 57.88   Max: 64.29
Current: 61.4

During the past 13 years, DaVita's highest Days Sales Outstanding was 64.29. The lowest was 42.95. And the median was 57.88.

BSP:DVAI34's Days Sales Outstanding is ranked worse than
65.31% of 637 companies
in the Healthcare Providers & Services industry
Industry Median: 46.01 vs BSP:DVAI34: 61.40

DaVita's Days Sales Outstanding declined from Dec. 2022 (66.01) to Dec. 2023 (58.42).


DaVita Days Sales Outstanding Historical Data

The historical data trend for DaVita's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DaVita Days Sales Outstanding Chart

DaVita Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 56.95 51.46 56.82 66.69 64.18

DaVita Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 66.01 66.78 64.14 58.47 58.42

Competitive Comparison of DaVita's Days Sales Outstanding

For the Medical Care Facilities subindustry, DaVita's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DaVita's Days Sales Outstanding Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DaVita's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where DaVita's Days Sales Outstanding falls into.



DaVita Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

DaVita's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (11183.56 + 9735.197) / 2 ) / 59484.292*365
=10459.3785 / 59484.292*365
=64.18

DaVita's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (10000.013 + 9735.197) / 2 ) / 15413.531*365 / 4
=9867.605 / 15413.531*365 / 4
=58.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DaVita  (BSP:DVAI34) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


DaVita Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of DaVita's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


DaVita (BSP:DVAI34) Business Description

Traded in Other Exchanges
Address
2000 16th Street, Denver, CO, USA, 80202
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

DaVita (BSP:DVAI34) Headlines

No Headlines